Related Experiment Video

Updated: Aug 13, 2026

Identification of EGFR and RAS Inhibitors using Caenorhabditis elegans
08:12

Identification of EGFR and RAS Inhibitors using Caenorhabditis elegans

Published on: October 5, 2020

Merlin inhibits growth hormone-regulated Raf-ERKs pathways by binding to Grb2 protein

Jung Yeon Lim1, Hongtae Kim, Sin-Soo Jeun

  • 1Department of Neurosurgery, The Catholic University of Korea, Seoul 137-701, Republic of Korea, and Department of Oncology Research, Mayo Clinic, Rochester, MN 55905, USA.

Biochemical and Biophysical Research Communications
|January 13, 2006
PubMed

Insights

The NF2 protein merlin inhibits abnormal cell proliferation by blocking growth hormone signaling pathways. Merlin

Area of Science:

  • Molecular Biology
  • Cell Biology
  • Cancer Research

Background:

  • The NF2 protein merlin is implicated in regulating cell growth and proliferation.
  • Understanding merlin's tumor suppressor mechanisms is crucial for cancer research.

Purpose of the Study:

  • To investigate merlin's action on cell proliferative signaling pathways in response to growth hormone (GH).
  • To elucidate merlin's molecular mechanisms in inhibiting tumorigenesis.

Main Methods:

  • Examined merlin's effect on GH-induced transcriptional activation (SRE and Elk-1) in NIH3T3 cells.
  • Assessed merlin's impact on Raf-1 complex activation and downstream signaling.
  • Investigated merlin's interaction with and effect on growth factor receptor bound 2 (Grb2) protein.

Main Results:

  • Merlin attenuated GH-induced SRE and Elk-1 transcriptional activation and c-fos expression.
  • Merlin inhibited Raf-1 activation, suppressing MAP kinase/ERK and Elk-1 phosphorylation.
  • Merlin interacted with Grb2 and inhibited its expression, impacting MAPK pathways.

Conclusions:

  • Merlin inhibits abnormal cell proliferation by interacting with Grb2 and suppressing MAPK signaling pathways.
  • These findings provide a deeper understanding of merlin's tumor suppressor function.

More Related Videos

Induction of Mesenchymal-Epithelial Transitions in Sarcoma Cells11:42

Induction of Mesenchymal-Epithelial Transitions in Sarcoma Cells

Published on: April 7, 2017

Spatial and Temporal Analysis of Active ERK in the C. elegans Germline08:40

Spatial and Temporal Analysis of Active ERK in the C. elegans Germline

Published on: November 29, 2016

Related Concept Videos

MAPK Signaling Cascades01:07

MAPK Signaling Cascades

Mitogen-activated protein kinase, or MAPK pathway, activates three sequential kinases to regulate cellular responses such as proliferation, differentiation, survival, and apoptosis. The canonical MAPK pathway starts with a mitogen or growth factor binding to an RTK. The activated RTKs stimulate Ras, which recruits Raf or MAP3 Kinase (MAPKKK), the first kinase of the MAPK signaling cascade. Raf further phosphorylates and activates MEK or MAP2 Kinases (MAPKK), which in turn phosphorylates MAP...
Small GTPases - Ras and Rho01:24

Small GTPases - Ras and Rho

Ras and Rho are small monomeric GTPases that act downstream of receptor tyrosine kinase (RTK) and regulate various cellular processes. These GTPases switch between active and inactive states by binding to guanine nucleotides.
Three regulatory proteins control their activity:
PI3K/mTOR/AKT Signaling Pathway01:22

PI3K/mTOR/AKT Signaling Pathway

The mammalian target of rapamycin  (mTOR) is a serine/threonine kinase that regulates growth, proliferation, and cell survival in response to hormones, growth factors, or nutrient availability. This kinase exists in two structurally and functionally distinct forms: mTOR complex 1  (mTORC1) and mTOR complex 2  (mTORC2). The first form (mTORC1) is composed of a rapamycin-sensitive Raptor and proline-rich Akt substrate, PRAS40. In contrast,  mTORC2 consists of a rapamycin-insensitive companion...
mTOR Signaling and Cancer Progression03:03

mTOR Signaling and Cancer Progression

The mammalian target of rapamycin or mTOR protein was discovered in 1994 due to its direct interaction with rapamycin. The protein gets its name from a yeast homolog called TOR. The mTOR protein complex in mammalian cells plays a major role in balancing anabolic processes such as the synthesis of proteins, lipids, and nucleotides and catabolic processes, such as autophagy in response to environmental cues, such as availability of nutrients and growth factors.
The mTOR pathway or the...
TGF - β Signaling Pathway01:16

TGF - β Signaling Pathway

The TGF-β signaling pathway regulates cell growth, differentiation, adhesion, motility, and development. TGF-β ligands that induce TGF-β signaling are synthesized in their latent form. Several proteases or cell surface receptors such as integrins act upon the latent form, releasing the active ligand. There are three types of mammalian TGF-βs: (TGF-β1, TGF-β2, and TGF-β3) that bind as homodimers or heterodimers to TGF-β receptors. The TGF-β receptors are of three kinds RI, RII, and RIII. The RI...
Mitogens and the Cell Cycle02:38

Mitogens and the Cell Cycle

Mitogens and their receptors play a crucial role in controlling the progression of the cell cycle. However, the loss of mitogenic control over cell division leads to tumor formation. Therefore, mitogens and mitogen receptors play an important role in cancer research. For instance, the epidermal growth factor (EGF) - a type of mitogen and its transmembrane receptor (EGFR), decides the fate of the cell's proliferation. When EGF binds to EGFR, a member of the ErbB family of tyrosine kinase...